Latest Earnings Results: Q2 '26
Estimated EPS
$0.34
Reported EPS
$0.40
Surprise
+19.13%
Estimated Rev
$985.62M
Reported Rev
$972.5M
Surprise
-1.33%
• Reported GAAP EPS of $0.40 up 110.53% YoY • Reported revenue of $972.52M up 48.52% YoY • Astrana Health provides guidance for the three months ending September 30, 2026, with total revenue of $1,000M to $1,030M and Adjusted EBITDA of $72.5M to $77.5M for the period.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.45 | -- | -- | N/A |
Q2 '26 | $0.34 | $0.40 | 19.13% | BEAT |
Q1 '26 | $0.30 | $0.29 | -2.92% | MISSED |
Q4 '25 | $0.11 | $0.12 | 6.67% | BEAT |
Q3 '25 | $0.47 | $0.01 | -97.86% | MISSED |